Keywords: ضد انعقاد خوراکی; ACS; Acute Coronary Syndrome; AF; atrial fibrillation; BMS; bare metal stent; CV; cardiovascular; DAPT; dual antiplatelet therapy; DES; drug eluting stent; OAC; oral anticoagulant; MACE; major adverse cardiovascular event; MI; myocardial infarction; NOAC;
مقالات ISI ضد انعقاد خوراکی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد انعقاد خوراکی; Non-valvu atrial fibrillation; Dual antiplatelet therapy; Direct oral anticoagulant; Oral anticoagulant;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Stroke; Catheter ablation; Oral anticoagulant; VKA; DOAC; Thromboembolic events; Systematic review; Meta-analysis;
Keywords: ضد انعقاد خوراکی; OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
Keywords: ضد انعقاد خوراکی; atrial fibrillation; Delta CHA2DS2-VASc score; ischemic stroke; slope; AF; atrial fibrillation; AUC; area under the receiver-operating characteristic curve; CI; confidence interval; HR; hazard ratio; IQR; interquartile range; NHI; National Health Insuranc
Keywords: ضد انعقاد خوراکی; Atrial fibrillation burden; Diagnosis; Clinical outcomes; Anticoagulation; AF; atrial fibrillation; AHRE; atrial high rate episode; CI; confidence interval; CIED; cardiac implantable electronic device; CRT; cardiac resynchronization therapy; ECG; electroc
Keywords: ضد انعقاد خوراکی; Prothrombin time-international normalized ratio; oral anticoagulant; atrial fibrillation; warfarin; time in therapeutic range; DOAC;
Keywords: ضد انعقاد خوراکی; Oral anticoagulant; Anticoagulation control; Warfarin; INR; Medication adherence; Saudi Arabia; MMAS-8
Keywords: ضد انعقاد خوراکی; INR; international normalized ratio; ISI; international sensitivity index; POC; point-of-care; PT; prothrombin time; VKA; vitamin K antagonist; Point-of-care testing; International normalized ratio; Vitamin K antagonist; Oral anticoagulant; Prothrombin ti
Keywords: ضد انعقاد خوراکی; ACC/AHA; American College of Cardiology/American Heart Association; AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, and prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive heart
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulant; Antiplatelet drugs; Warfarin; Chinese;
Keywords: ضد انعقاد خوراکی; ACC/AHA; American College of Cardiology/American Heart Association; ACS; acute coronary syndrome; ADP; adenosine diphosphate; AF; atrial fibrillation; BRIGHT; Bivalirudin in Acute Myocardial Infarction vs Heparin and GPI Plus Heparin Trial; CAD; coronary
Keywords: ضد انعقاد خوراکی; oral anticoagulant; warfarin; vitamin K antagonist; pharmacogenomics; algorithm
Keywords: ضد انعقاد خوراکی; ACEi; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; A-II; angiotensin-II; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; BP; blood pressure; BMI; body mass index; BNP; brain natriuretic peptide; CaMKII; calmodulin-
Keywords: ضد انعقاد خوراکی; extended treatment; oral anticoagulant; recurrent venous thromboembolism; venous thromboembolism; VTE;
Keywords: ضد انعقاد خوراکی; AF; Atrial fibrillation; OAC; Oral anticoagulant; INR; International normalised ratio; TTR; Time in therapeutic range; NOAC; Novel oral anticoagulant; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVER
Keywords: ضد انعقاد خوراکی; Intracerebral hemorrhage; Oral anticoagulant; Warfarin; Hematoma; International normalized ratio; Brain stem hemorrhage;
Dabigatran Reversal in a Patient With End-Stage Liver Disease and Acute Kidney Injury
Keywords: ضد انعقاد خوراکی; Dabigatran; end-stage liver disease (ESLD); acute kidney injury (AKI); thrombin inhibitor; oral anticoagulant; renal clearance; hemorrhage; bleeding; dose adjustment; drug safety; decreased kidney function; idarucizumab;
Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time
Keywords: ضد انعقاد خوراکی; Dabigatran; Oral anticoagulant; Partial thromboplastin time; Blood coagulation tests; Surgery;
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; AKI; acute kidney injury; CHA2DS2-VASc; congestive heart failure, hypertension, aged 75â¯years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, aged 65 to 74â¯years, female; CKD; chronic
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; AMADEUS; Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation; CHA2DS2-VASc; Congestive heart failure or left ventricular dysfunction (1), Hypertension (1), Ageâ¥75 (2) or 65-74
Characteristics and outcomes of reversed patients admitted to an emergency department for VKA-related intramuscular hematoma
Keywords: ضد انعقاد خوراکی; Oral anticoagulant; VKA; Major bleeding; Intramuscular hematoma, ISTH criteria;
Peri-Procedural Management of Oral Anticoagulants in the DOAC Era
Keywords: ضد انعقاد خوراکی; Oral anticoagulant; Direct oral anticoagulant (DOAC); Warfarin; Peri-procedural management;
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; CrCl; creatinine clearance; ISTH; International Society on Thrombosis and Haemostasis; NOAC; non-vitamin K antagonist OACs; NVAF; non-valvular atrial fibrillation; OAC; oral anticoagulant; PT-INR; prothrombin time-international no
Hémorragies intracrâniennes et anticoagulantes orales de patients traités entre 2011 à 2013. Ãtude descriptive au CHRU de Nancy
Keywords: ضد انعقاد خوراکی; Intracranial hemorrhage; Oral anticoagulant; Hospitalization; Hémorragie intracrânienne; Anticoagulant oral; Hospitalisation;
Observance du traitement anticoagulant oral chez le sujet âgé à l'ère des anticoagulants oraux directs
Keywords: ضد انعقاد خوراکی; Observance; Médecine générale; Anticoagulant oral; Fibrillation atriale; Sujets âgés; Adherence; General medicine; Oral anticoagulant; Atrial fibrillation; Elderly people;
Transurethral bipolar plasmakinetic vapo-enucleation of the prostate: Is it safe for patients on chronic oral anticoagulants and/or platelet aggregation inhibitors?
Keywords: ضد انعقاد خوراکی; Hb; haemoglobin; HoLEP; holmium laser enucleation of the prostate; INR; international normalised ratio; M-TURP; monopolar TURP; OA; oral anticoagulant; PAI; platelet aggregation inhibitor; PKERP; plasmakinetic enucleation and resection of the prostate; PV
Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study)
Keywords: ضد انعقاد خوراکی; Antiplatelet; Cross-sectional study; Nonvalvular atrial fibrillation; Oral anticoagulant;
Persistence With Dabigatran Therapy at 2Â Years in Patients With Atrial Fibrillation
Keywords: ضد انعقاد خوراکی; discontinuation; non-VKA oral anticoagulant; oral anticoagulation; stroke prevention; vitamin K antagonist; AE; adverse event; AF; atrial fibrillation; CI; confidence interval; HR; hazard ratio; NOAC; non-vitamin K oral anticoagulant; OAC; oral anticoag
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of Cardiology
Keywords: ضد انعقاد خوراکی; Acute coronary syndromes; Aspirin; Bleeding; Clopidogrel; Coronary artery bypass grafting; Coronary artery disease; DAPT score; Drug-eluting stents; Dual antiplatelet therapy; Guidelines; Myocardial infarction; Non-cardiac surgery; Oral anticoagulant; Per
Short communicationInteractions between non-vitamin K oral anticoagulants and antiepileptic drugs
Keywords: ضد انعقاد خوراکی; AED; antiepileptic drug; AF; atrial fibrillation; DDI; drug-drug interaction; INR; International Normalized Ratio; NOAC; non-vitamin K antagonist oral anticoagulant; OAC; oral anticoagulant; VKA; vitamin-K antagonist; Atrial fibrillation; Stroke; Seizur
Current status of catheter ablation of atrial fibrillation in Japan: Summary of the 4th survey of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Catheter ablation; Oral anticoagulant; Complication; Pulmonary vein isolation
Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry
Keywords: ضد انعقاد خوراکی; Nonvalvular atrial fibrillation; Antiarrhythmic therapy; Cardioversion; Ablation; FANTASIIA registry; Fibrilación auricular no valvular; Tratamiento antiarrÃtmico; Cardioversión; Ablación; Registro FANTASIIA; AF; atrial fibrillation; HF; heart failure
Initial experience with the WATCHMAN⢠left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry
Keywords: ضد انعقاد خوراکی; Left atrial appendage closure; WATCHMANâ¢; Fibrillation auriculaire; Occlusion de l'auricule gauche; Prévention de l'accident vasculaire cérébral ischémique; Prothèse de WATCHMANâ¢; AF; atrial fibrillation; CHADS2; Cardiac failure, Hypertension
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome
Keywords: ضد انعقاد خوراکی; ACC; American College of Cardiology; ACS; acute coronary syndrome; AHA; American Heart Association; BMS; bare metal stent; CI; contraindication; CKD; chronic kidney disease; CTO; chronic total occlusion; DAPT; dual antiplatelet therapy; DES; drug-eluting
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulant; Thromboembolic risk;
Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; APHRS; Asia Pacific Heart Rhythm Society; CI; confidence interval; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; NHI; National Health Insurance; NHIRD; National Health Insurance Researc
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
Keywords: ضد انعقاد خوراکی; DOAC; Direct thrombin inhibitor; Direct Xa inhibitor; Oral anticoagulant; Laboratory assays;
An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal
Keywords: ضد انعقاد خوراکی; Prothrombin complex concentrate; Prothromplex total; Anticoagulant reversal; Oral anticoagulant; Vitamin K antagonists;
The safety and efficacy of vitamin K antagonist in patients with atrial fibrillation and liver cirrhosis
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; CP; Child-Pugh; LC; liver cirrhosis; SCE; significant clinical event; VKA; vitamin K antagonist; Atrial fibrillation; Stroke; Hemorrhage; Oral anticoagulant; Vitamin K antagonist; Liver cirrhosis;
Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMANÂ Randomized Trial Experience
Keywords: ضد انعقاد خوراکی; atrial fibrillation; bleeding; left atrial appendage; left atrial appendage closure; WATCHMAN; AF; atrial fibrillation; LAA; left atrial appendage; NOAC; non-vitamin K-dependent oral anticoagulant; OAC; oral anticoagulant; RRR; relative risk reduction;
Ulcérations récidivantes à type de pyoderma grangrenosum induites par les antivitamines K
Keywords: ضد انعقاد خوراکی; Ulcère induit; Antivitamines K; Pyoderma gangrenosum; Vasculite leucocytoclasique; Induced skin ulcer; Oral anticoagulant; Pyoderma gangrenosum; Leukocytoclastic angiitis;
Peribulbar versus sub-Tenon block in cardiac patients undergoing cataract surgery during warfarin therapy
Keywords: ضد انعقاد خوراکی; Subtenon; Peribulbar block; Oral anticoagulant; Cataract surgery
Les entretiens AVK : bilan d’étape
Keywords: ضد انعقاد خوراکی; Anticoagulant oral; Dispensation; Entretien pharmaceutique; Iatrogénie; INR; ObservanceCompliance; Dispensing; Iatrogenesis; INR; Oral anticoagulant; Pharmaceutical interview
A case series of LMWH use in pregnancy: Should trough anti-Xa levels guide dosing?
Keywords: ضد انعقاد خوراکی; AMS; Anticoagulation Management Service; BID; twice daily; CrCl; creatinine clearance; CVA; cerebrovascular accident; IV; intravenous; LMWH; low molecular weight heparin; MHV; mechanical heart valves; NA; not applicable; OAC; oral anticoagulant; OMC; Obst
Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats
Keywords: ضد انعقاد خوراکی; APTT; activated partial thromboplastin time; BID; twice daily; DVT; deep vein thrombosis; factor Xa; activated factor X; HE; hematoxylin and eosin; PE; pulmonary embolism; PT; prothrombin time; PTAH; phosphotungstic acid hematoxylin; QD; once daily; S.E.M
Antithrombotic and anticoagulant effects of direct factor Xa inhibitor darexaban in rat and rabbit models of venous thrombosis
Keywords: ضد انعقاد خوراکی; Oral anticoagulant; Factor Xa inhibitor; Venous thrombosis; Bleeding; Platelet;
National survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J-CARAF)
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Catheter ablation; Oral anticoagulant; Complication; Pulmonary vein isolation
New-generation oral anticoagulants for the prevention of stroke: Implications for neurosurgery
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Dabigatran; Neurosurgery; Intracranial hemorrhage; Oral anticoagulant; Reversal
Outpatient Management of Oral Anticoagulation in Atrial Fibrillation
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulant; Stroke risk; Treatment; Outpatients;